Zafardoust, Simin http://orcid.org/0000-0002-9536-395X
Kazemnejad, Somaieh
Fathi-Kazerooni, Mina
Darzi, Maryam
Sadeghi, Mohammad Reza
Sadeghi Tabar, Ali
Sehat, Zahra
Clinical trials referenced in this document:
Documents that mention this clinical trial
The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response
https://doi.org/10.1186/s13287-023-03568-1
Funding for this research was provided by:
Avicenna Research Institute (990304– 008)
Article History
Received: 21 February 2023
Accepted: 9 November 2023
First Online: 15 November 2023
Declarations
:
: This clinical study was conducted with the permission of the Ethics Committee for Biomedical Research of the Academic Center for Education, Culture, and Research (ACECR, Tehran, Iran) (IR.ACECR.REC.1399.002, 2020-05-31) under the title "Effectiveness evaluation of intra-ovarian injection of autologous menstrual blood stem cells in fertility potential of patients with poor ovarian response: a controlled clinical trial study". The procedures observed were in accordance with the Declaration of Helsinki, Good Clinical Practice (GCP), and GMP guidelines. Furthermore, this study was registered with the Iranian Clinical Trials Registry (IRCT20180619040147N2) and ClinicalTrials.gov (NCT05703308). The cell manufacturing was completed with approval from the Food and Drug Administration of Iran at STERCO (Iran, Tehran) in a GMP clean room. All participants provided informed consent prior to commencing the study.
: Not relevant.
: The authors declare that they have no competing interests.